Isoray (NYSE-A:ISR) Inc CEO Lori Woods joined Steve Darling from Proactive to share news about the company's potential merger with Viewpoint Molecular Targeting. Woods telling Proactive this move will be a transformational opportunity for the company and a shareholder vote will be happening in the next several weeks. Woods also talked about 2023 and some of the catalysts the company is looking for to move the merged companies forward.
Isoray's merger with Viewpoint Molecular Targeting sets up big opportunity in 2023
